Posts by David A. Bichara, MD
-
Novel Drug-eluting Polymer May Improve Treatment of Prosthetic Joint Infection
The standard treatment for prosthetic joint infection requires patients to endure two surgeries beyond the original procedure, plus periods of inactivity. A new drug-eluting polymer developed at Mass General might change all that.
Biography
Dr. Bichara is responsible for the experimental design and oversight of studies evaluating biocompatibility and in vivo performance of implants engineered in the Harris Laboratory. He has extensive experience developing clinically-relevant models to predict implant performance and determining the biologic effects of implant failure. His research focuses on therapies to treat osteochondral defects using hydrogel-based technologies and strategies to prevent particle-induced osteolysis. He has authored 19 peer-reviewed publications, has been awarded grants by the American Society of Maxillofacial Surgeons, and currently mentors post-doctoral research fellows and graduate students. After completing clinical clerkships at the Massachusetts General Hospital, Dr. Bichara earned his medical degree from the University of Monterrey, Mexico, graduating cum laude. He is currently a Research Scientist at the Massachusetts General Hospital and an Instructor in Orthopaedics Surgery at Harvard Medical School.
Orthopaedic Care at Mass General
At Mass General, our world-class physicians and surgeons treat the full spectrum of musculoskeletal conditions throughout the body, from sprains and strains on the athletic field to carpal tunnel syndrome. Our team offers innovative, research-based treatments that range from limb-saving oncological procedures to complex spinal reconstruction.